The evolution of proton beam therapy: Current and future status (Review)
- Authors:
- Xiufang Tian
- Kun Liu
- Yong Hou
- Jian Cheng
- Jiandong Zhang
-
Affiliations: Department of Radiation Oncology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China - Published online on: November 14, 2017 https://doi.org/10.3892/mco.2017.1499
- Pages: 15-21
This article is mentioned in:
Abstract
 |
|
Wilson RR: Radiological use of fast protons. Radiology. 47:487–491. 1946. View Article : Google Scholar : PubMed/NCBI | |
|
Lawrence JH, Tobias CA, Born JL, McCombs RK, Roberts JE, Anger HO, Low-Beer BV and Huggins CB: Pituitary irradiation with high-energy proton beams: A preliminary report. Cancer Res. 18:121–134. 1958.PubMed/NCBI | |
|
Bragg WH and Kleeman R: XXXIX. On the α particles of radium, and their loss of range in passing through various atoms and molecules. Philos Mag. 10:318–340. 1905. View Article : Google Scholar | |
|
Jäkel O, Smith AR and Orton CG: The more important heavy charged particle radiotherapy of the future is more likely to be with heavy ions rather than protons. Med Phys. 40:0906012013. View Article : Google Scholar : PubMed/NCBI | |
|
Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS and Suit HD: Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 53:407–421. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS and Suit HD: Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 53:407–421. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Van de Water TA, Lomax AJ, Bijl HP, De Jong ME, Schilstra C, Hug EB and Langendijk JA: Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 79:1216–1224. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Slater JD, Yonemoto LT, Mantik DW, Bush DA, Preston W, Grove RI, Miller DW and Slater JM: Proton radiation for treatment of cancer of the oropharynx: Early experience at Loma Linda university medical center using a concomitant boost technique. Int J Radiat Oncol Biol Phys. 62:494–500. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fitzek MM, Thornton AF, Varvares M, Ancukiewicz M, Mcintyre J, Adams J, Rosenthal S, Joseph M and Amrein P: Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer. 94:2623–2634. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Truong MT, Kamat UR, Liebsch NJ, Curry WT, Lin DT, Barker FG II, Loeffler JS and Chan AW: Proton radiation therapy for primary sphenoid sinus malignancies: Treatment outcome and prognostic factors. Head Neck. 31:1297–1308. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fuji H, Yoshikawa S, Kasami M, Murayama S, Onitsuka T, Kashiwagi H and Kiyohara Y: High-dose proton beam therapy for sinonasal mucosal malignant melanoma. Radiat Oncol. 9:1622014. View Article : Google Scholar : PubMed/NCBI | |
|
Moriarty JP, Borah BJ, Foote RL, Pulido JS and Shah ND: Cost-effectiveness of proton beam therapy for intraocular melanoma. PLoS One. 10:e01278142015. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmed KA, Demetriou SK, McDonald M and Johnstone PA: Clinical benefits of proton beam therapy for tumors of the skull base. Cancer Control. 23:213–219. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sakurai H, Ishikawa H and Okumura T: Proton beam therapy in Japan: Current and future status. Jpn J Clin Oncol. 46:885–892. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Berman AT, James SS and Rengan R: Proton beam therapy for non-small cell lung cancer: Current clinical evidence and future directions. Cancers (Basel). 7:1178–1190. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CT, Motegi A, Motegi K, Hotta K, Kohno R, Tachibana H, Kumagai M, Nakamura N, Hojo H, Niho S, et al: Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer. Jpn J Clin Oncol. Aug 10–2016.(Epub ahead of print). View Article : Google Scholar | |
|
Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E and Choy H: Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. J Clin Oncol. 28:2475–2480. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Iwata H, Demizu Y, Fujii O, Terashima K, Mima M, Niwa Y, Hashimoto N, Akagi T, Sasaki R, Hishikawa Y, et al: Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer. J Thorac Oncol. 8:726–735. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dunlap NE, Larner JM, Read PW, Kozower BD, Lau CL, Sheng K and Jones DR: Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT. J Thorac Cardiovasc Surg. 140:583–589. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kanemoto A, Okumura T, Ishikawa H, Mizumoto M, Oshiro Y, Kurishima K, Homma S, Hashimoto T, Ohkawa A, Numajiri H, et al: Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non-small-cell lung cancer. Clin Lung Cancer. 15:e7–e12. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Socinski MA, Blackstock AW, Bogart JA, Wang X, Munley M, Rosenman J, Gu L, Masters GA, Ungaro P, Sleeper A, et al: Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer. J Clin Oncol. 26:2457–2463. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Koto M, Takai Y, Ogawa Y, Matsushita H, Takeda K, Takahashi C, Britton KR, Jingu K, Takai K, Mitsuya M, et al: A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol. 85:429–434. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenman JG, Halle JS, Socinski MA, Deschesne K, Moor DT, Johnson H, Fraser R and Morris DE: High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys. 54:348–356. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Schild SE, Rule WG, Ashman JB, Vora SA, Keole S, Anand A, Liu W and Bues M: Proton beam therapy for locally advanced lung cancer: A review. World J Clin Oncol. 5:568–575. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R and Cox JD: Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall celllung cancer. Cancer. 117:4707–4713. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cox JD: Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys. 82:1042–1044. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Oshiro Y, Okumura T, Kurishima K, Homma S, Mizumoto M, Ishikawa H, Onizuka M, Sakai M, Goto Y, Hizawa N, et al: High-dose concurrent chemo-proton therapy for Stage III NSCLC: Preliminary results of a Phase II study. J Radiat Res. 55:959–965. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, et al: Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): A randomised, two-by-two factorial phase 3 study. Lancet Oncol. 16:187–199. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ohno T, Oshiro Y, Mizumoto M, Numajiri H, Ishikawa H, Okumura T, Terunuma T, Sakae T and Sakurai H: Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer. J Radiat Res. 56:128–133. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Takada A, Nakamura T, Takayama K, Makita C, Suzuki M, Azami Y, Kato T, Tsukiyama I, Hareyama M, Kikuchi Y, et al: Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer. Cancer Med. 5:506–515. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y and Fukuda H; Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG), : Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 81:684–690. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T and Yoshida S: Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 21:2697–2702. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, Nonaka T, Ishikawa H, Katoh H, Takahashi T and Nakano T: Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys. 80:1002–1007. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, Ito H and Yamashita T: Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys. 75:122–128. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Okonogi N, Hashimoto T, Ishida M, Ohno T, Terunuma T, Okumura T, Sakae T and Sakurai H: Designed-seamless irradiation technique for extended whole mediastinal proton-beam irradiation foresophageal cancer. Radiat Oncol. 7:1732012. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikawa H, Hashimoto T, Moriwaki T, Hyodo I, Hisakura K, Terashima H, Ohkohchi N, Ohno T, Makishima H, Mizumoto M, et al: Proton beam therapy combined with concurrent chemotherapy for esophageal cancer. Anticancer Res. 35:1757–1762. 2015.PubMed/NCBI | |
|
Koyama S and Tsujii H: Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. Clin Cancer Res. 9:3571–3577. 2003.PubMed/NCBI | |
|
Mizumoto M, Sugahara S, Nakayama H, Hashii H, Nakahara A, Terashima H, Okumura T, Tsuboi K, Tokuuye K and Sakurai H: Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol. 186:482–488. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sugahara S, Tokuuye K, Okumura T, Nakahara A, Saida Y, Kagei K, Ohara K, Hata M, Igaki H and Akine Y: Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys. 61:76–84. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Makishima H, Ishikawa H, Terunuma T, Hashimoto T, Yamanashi K, Sekiguchi T, Mizumoto M, Okumura T, Sakae T and Sakurai H: Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis. J Radiat Res. 56:568–576. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lin SH, Hallemeier CL and Chuong M: Proton beam therapy for the treatment of esophageal cancer. Chin Clin Oncol. 5:532016. View Article : Google Scholar : PubMed/NCBI | |
|
Ono T, Nakamura T, Azami Y, Yamaguchi H, Hayashi Y, Suzuki M, Hatayama Y, Tsukiyama I, Hareyama M, Kikuchi Y and Nemoto K: Clinical results of proton beam therapy for twenty older patients with esophageal cancer. Radiol Oncol. 49:371–378. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chuong MD, Hallemeier CL, Jabbour SK, Yu J, Badiyan S, Merrell KW, Mishra MV, Li H, Verma V and Lin SH: Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys. 95:488–497. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Reiazi R, Norozi A and Etedadialiabadi M: A Literature survey on cost-Effectiveness of proton beam therapy in the management of breast cancer patients. Iran J Cancer Prev. 8:e43732015. View Article : Google Scholar : PubMed/NCBI | |
|
Johansson J, Isacsson U, Lindman H, Montelius A and Glimelius B: Node-positive left-sided breast cancer patients after breast-conserving surgery: Potential outcomes of radiotherapy modalities and techniques. Radiother Oncol. 65:89–98. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kozak KR, Smith BL, Adams J, Kornmehl E, Katz A, Gadd M, Specht M, Hughes K, Gioioso V, Lu HM, et al: Accelerated partial-breast irradiation using proton beams: Initial clinical experience. Int J Radiat Oncol Biol Phys. 66:691–698. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kozak KR, Katz A, Adams J, Crowley EM, Nyamwanda JA, Feng JK, Doppke KP, Delaney TF and Taghian AG: Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 65:1572–1578. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lomax AJ, Cella L, Weber D, Kurtz JM and Miralbell R: Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys. 55:785–792. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bush DA, Slater JD, Garberoglio C, Do S, Lum S and Slater JM: Partial breast irradiation delivered with proton beam: Results of a phase II trial. Clin Breast Cancer. 11:241–245. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Weber DC, Ares C, Lomax AJ and Kurtz JM: Radiation therapy planning with photons and protons for early and advanced breast cancer: An overview. Radiat Oncol. 1:222006. View Article : Google Scholar : PubMed/NCBI | |
|
Lundkvist J, Ekman M, Ericsson SR, Isacsson U, Jönsson B and Glimelius B: Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol. 75:179–185. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 366:2087–2106. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bush DA, Slater JD, Garberoglio C, Yuh G, Hocko JM and Slater JM: A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy. Cancer J. 13:114–118. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Taghian AG, Kozak KR, Katz A, Adams J, Lu HM, Powell SN and DeLaney TF: Accelerated partial breast irradiation using proton beams: initial dosimetric experience. Int J Radiat Oncol Biol Phys. 65:1404–1410. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mahal BA, Chen YW, Efstathiou JA, Muralidhar V, Hoffman KE, Yu JB, Feng FY, Beard CJ, Martin NE, Orio PF III and Nguyen PL: National trends and determinants of proton therapy use for prostate cancer: A national cancer data base study. Cancer. 122:1505–1512. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, et al: Comparative effectiveness study of patient-reported outcomes after proton therapy or intensitymodulated radiotherapy for prostate cancer. Cancer. 120:1076–1082. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sheets NC, Goldin GH, Meyer AM, Wu Y, Chang Y, Stürmer T, Holmes JA, Reeve BB, Godley PA, Carpenter WR and Chen RC: Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 307:1611–1620. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hospital MG, Pennsylvania Uo; (NCI) NCI, ; et al: Proton therapy vs. IMRT for low or intermediate risk prostate cancer (PARTIQoL). https://clinicaltrials.gov/ct2/show/NCT01617161June 12–2012 | |
|
Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, Dicker AP and Den RB: Evolution of advanced technologies in prostate cancer radiotherapy. Nat Rev Urol. 10:565–579. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Pugh TJ and Lee AK: Proton beam therapy for the treatment of prostate cancer. Cancer J. 20:415–420. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Johnstone PA, McMullen KP, Buchsbaum JC, Douglas JG and Helft P: Pediatric CSI: Are protons the only ethical approach? Int J Radiat Oncol Biol Phys. 87:228–230. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sethi RV, Shih HA, Yeap BY, Mouw KW, Petersen R, Kim DY, Munzenrider JE, Grabowski E, Rodriguez-Galindo C, Yock TI, et al: Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 120:126–133. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Taddei PJ, Mirkovic D, Fontenot JD, Giebeler A, Zheng Y, Kornguth D, Mohan R and Newhauser WD: Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams. Phys Med Biol. 54:2259–2275. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, Gajjar A and Mulhern RK: Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys. 65:210–221. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Miralbell R, Lomax A, Cella L and Schneider U: Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 54:824–829. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Athar BS and Paganetti H: Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiother Oncol. 98:87–92. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD and Smith AR: Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 63:362–372. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yock T, Schneider R, Friedmann A, Adams J, Fullerton B and Tarbell N: Proton radiotherapy for orbital rhabdomyosarcoma: Clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys. 63:1161–1168. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Mu X, Björk-Eriksson T, Nill S, Oelfke U, Johansson KA, Gagliardi G, Gagliardi G, Johansson L, Karlsson M and Zackrisson DB: Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol. 44:554–562. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT and Hancock SL: Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol. 25:43–49. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hull MC, Morris CG, Pepine CJ and Mendenhall NP: Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA. 290:2831–2837. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, et al: The clinical case for proton beam therapy. Radiat Oncol. 7:1742012. View Article : Google Scholar : PubMed/NCBI | |
|
Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M and Cox JD: Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer. 117:3004–3013. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Plastaras JP, Berman AT and Freedman GM: Special cases for proton beam radiotherapy: Re-irradiation, lymphoma, and breast cancer. Semin Oncol. 41:807–819. 2014. View Article : Google Scholar : PubMed/NCBI |
